Skip to main content
. 2021 May 4;16:84. doi: 10.1186/s13014-021-01813-6

Fig. 3.

Fig. 3

Illustration of the benefit of reoptimization for patient A: (TOP) DVH comparison of baseline, rigidly shifted, and reoptimized plan; a Dose distribution of the baseline plan overlayed on the pre-treatment MR; b rigidly shifted plan overlayed on the MR of the first treatment fraction; c reoptimized plan for the first treatment fraction. Doses exceeding 45 Gy are shown. The contours displayed are the PTV (red) and the heart (rose)